Schedule 13D ownership disclosure

CINCOR PHARMA INC

Security class unavailable · CUSIP: 17240Y109

Event date: 2023-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,953,990
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-004590
Form type
SC 13D
Filer
5AM Ventures VI, L.P.
CIK
CIK 1753037
Filed
Jan 18, 2023
Reporting period
Jan 08, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub